79 related articles for article (PubMed ID: 23991141)
1. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis.
Bilreiro C; Andrade L; Marques RM; Matos C
Eur Radiol; 2024 May; 34(5):3238-3248. PubMed ID: 37907761
[TBL] [Abstract][Full Text] [Related]
3. Can conventional magnetic resonance imaging at presentation predict chemoresistance in osteosarcoma?
Kanthawang T; Wudhikulprapan W; Phinyo P; Settakorn J; Pruksakorn D; Link TM; Pattamapaspong N
Br J Radiol; 2024 Feb; 97(1154):451-461. PubMed ID: 38308035
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction.
Ho DJ; Agaram NP; Jean MH; Suser SD; Chu C; Vanderbilt CM; Meyers PA; Wexler LH; Healey JH; Fuchs TJ; Hameed MR
Am J Pathol; 2023 Mar; 193(3):341-349. PubMed ID: 36563747
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Prognostic Value of Pretherapeutic Magnetic Resonance Imaging in Predicting Soft Tissue Sarcoma Radiation Response: A Retrospective Study from a Large Institutional Sarcoma Imaging Database.
Vogin G; Lepage M; Salleron J; Cuenin M; Blum A; Gondim Teixeira PA
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473238
[No Abstract] [Full Text] [Related]
7. Diagnostic assessment of osteosarcoma chemoresistance based on Virtual Clinical Trials.
Rejniak KA; Lloyd MC; Reed DR; Bui MM
Med Hypotheses; 2015 Sep; 85(3):348-54. PubMed ID: 26130106
[TBL] [Abstract][Full Text] [Related]
8. The use of weakly supervised machine learning for necrosis assessment in patients with osteosarcoma: A pilot study.
LiBrizzi CL; Wang Z; Sulam J; James AW; Levin AS; Morris CD
J Orthop Res; 2024 Feb; 42(2):453-459. PubMed ID: 37799037
[TBL] [Abstract][Full Text] [Related]
9. Systemic Cisplatin Does Not Affect the Bone Regeneration Process in a Critical Size Defect Murine Model.
Brozovich AA; Lenna S; Brenner C; Serpelloni S; Paradiso F; McCulloch P; Yustein JT; Weiner B; Taraballi F
ACS Biomater Sci Eng; 2024 Mar; 10(3):1646-1660. PubMed ID: 38350651
[TBL] [Abstract][Full Text] [Related]
10. Manual and Semi-Automated Measurement and Calculation of Osteosarcoma Treatment Effect Using Whole Slide Image and Qupath.
He M; He B; Weng J; Cheng JQ; Gu H
Pediatr Dev Pathol; 2024; 27(1):32-38. PubMed ID: 37943723
[TBL] [Abstract][Full Text] [Related]
11. Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma.
Kawaguchi K; Miyama K; Endo M; Bise R; Kohashi K; Hirose T; Nabeshima A; Fujiwara T; Matsumoto Y; Oda Y; Nakashima Y
NPJ Precis Oncol; 2024 Jan; 8(1):16. PubMed ID: 38253709
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Osteosarcoma Mineralization on Plain Radiographs - Novel Software Applications to Assess Response to Chemotherapy.
Xu X; Samkoe KS; Anderson ME; Henderson ER
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11224():. PubMed ID: 32483398
[TBL] [Abstract][Full Text] [Related]
13. Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF.
Mustokoweni S; Mahyudin F; Setiawati R; Nugrahenny D; Hidayat M; Kalim H; Mintaroem K; Fitri LE; Hogendoorn PCW
Virchows Arch; 2024 May; ():. PubMed ID: 38748263
[TBL] [Abstract][Full Text] [Related]
14. Weight loss and response to chemotherapy in pediatric patients with osteosarcoma.
Peled Y; Levin D; Manisterski M; Kollander N; Shukrun R; Elhasid R
Eur J Clin Nutr; 2024 Jan; ():. PubMed ID: 38238462
[TBL] [Abstract][Full Text] [Related]
15. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
Liu C; Xi Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Diffusion-Weighted Imaging in Neoadjuvant Chemotherapy for Osteosarcoma: A Systematic Review and Meta-Analysis.
Yuan W; Yu Q; Wang Z; Huang J; Wang J; Long L
Acad Radiol; 2022 Feb; 29(2):326-334. PubMed ID: 33386220
[TBL] [Abstract][Full Text] [Related]
17. Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?
Chatziantoniou C; Schoot RA; van Ewijk R; van Rijn RR; Ter Horst SAJ; Merks JHM; Leemans A; De Luca A
Insights Imaging; 2023 Jan; 14(1):19. PubMed ID: 36720720
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis.
Baidya Kayal E; Bakhshi S; Kandasamy D; Sharma MC; Khan SA; Kumar VS; Khare K; Sharma R; Mehndiratta A
J Transl Med; 2022 Dec; 20(1):625. PubMed ID: 36575510
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI evaluation of bone sarcomas in children.
Inarejos Clemente EJ; Navarro OM; Navallas M; Ladera E; Torner F; Sunol M; Garraus M; March JC; Barber I
Insights Imaging; 2022 Mar; 13(1):33. PubMed ID: 35229206
[TBL] [Abstract][Full Text] [Related]
20. Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.
Teo KY; Daescu O; Cederberg K; Sengupta A; Leavey PJ
PLoS One; 2022; 17(2):e0259564. PubMed ID: 35157711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
